SCHEMBL6667289

SCHEMBL6667289

COc1ccc(C(=O)CC(CC2CCCCC2)C(=O)O)cc1.O=C(CC(Cc1ccc2ccccc2c1)C(=O)O)c1ccccc1.O=C(CC(Cc1ccccc1)C(=O)O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.46
MCL1 Q07820 1/20 0.46
CTSL P07711 1/20 0.45
CTSS P25774 1/20 0.45
CTSK P43235 1/20 0.45
ALDH1A1 P00352 2/20 0.44
KMO O15229 1/20 0.42
MMP1 P03956 1/20 0.42
MMP2 P08253 1/20 0.42
MMP3 P08254 1/20 0.42
PTPN1 P18031 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
METAP2 P50579 1/20 0.40
METAP1 P53582 1/20 0.40
LTA4H P09960 1/20 0.40
MCHR1 Q99705 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6664357 0.96 CTSS (0.44) BCL2L1MCL1CTSLCTSSCTSK
SCHEMBL6668702 0.88 BCL2L1 (0.46) BCL2L1MCL1CTSLCTSSALDH1A1
SCHEMBL6669920 0.87 BCL2L1 (0.47) BCL2L1MCL1CTSSALDH1A1KMO
SCHEMBL3104440 0.83 ALDH1A1 (0.50) BCL2L1MCL1CTSSALDH1A1L3MBTL1
SCHEMBL6671105 0.82 KMO (0.54) BCL2L1MCL1ALDH1A1KMOPTPN1
SCHEMBL6674722 0.79 KMO (0.57) BCL2L1MCL1ALDH1A1KMOL3MBTL1
SCHEMBL16284887 0.79 NPC1 (0.60) KMOL3MBTL1
SCHEMBL16284888 0.79 NPC1 (0.60) KMOL3MBTL1
SCHEMBL6672877 0.79 NPC1 (0.60) KMOL3MBTL1
SCHEMBL3101828 0.79 NPC1 (0.60) KMOL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1448181-A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF METFORMIN AND A 4-OXOBUTANOIC ACID, AND THE USE THEREOF FOR TREATING DIABETES MERCK PATENT GmbH (DE) 2004-08-25 EP claimed
WO-2003045368-A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF METFORMIN AND A 4-OXOBUTANOIC ACID, AND THE USE THEREOF FOR TREATING DIABETES MERCK PATENT GMBH (DE) 2003-06-05 WO claimed